vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
21.03
-0.71 (-3.27%)
Nov 6, 2026, 4:00 PM EST - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $261.29 million as of November 6, 2026. It is the 18,793rd most valuable company in the world and the 3,307th biggest in the United States. Its market cap has increased by 36.30% in one year.
Market Cap
261.29M
Enterprise Value
184.13M
1-Year Change
36.30%
Global Rank
Country Rank
#3,307 United States
Category
ChartMarket Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $261.29M, an increase of 234.45%. That is a compound annual growth rate of 11.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 261.29M | -47.34% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 277.04M |
| Precision BioSciences | 275.73M |
| Nautilus Biotechnology | 273.85M |
| Century Therapeutics | 273.42M |
| Clinuvel Pharmaceuticals | 271.63M |
| Vogenx | 270.81M |
| SAB Biotherapeutics | 267.50M |
| Turn Therapeutics | 266.31M |